# The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma

> **NCT03034005** · PHASE4 · COMPLETED · sponsor: **Bispebjerg Hospital** · enrollment: 60 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT03034005
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-02-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03034005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03034005, "The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03034005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*